CatliGAbaciABoberEBüyükgebizA. Clinical and diagnostic characteristics of hyperprolactinemia in childhood and adolescence. J Pediatr Endocrinol Metab. 2013;26:1-11.
2.
de SoárezPCde Arêa Leão SouzaSCVieiraJGHFerrazMB. The effect of identifying macroprolactinemia on health-care utilization and costs in patients with elevated serum prolactin levels. Value Health. 2009;12:930-934.
3.
ShimatsuAHattoriN. Macroprolactinemia: diagnostic, clinical, and pathogenic significance. Clin Dev Immunol. 2012;2012:167132.
4.
KavanaghLMcKennaTJFahie-WilsonMNGibneyJSmithTP. Specificity and clinical utility of methods for the detection of macroprolactin. Clin Chem. 2006;52:1366-1372.
5.
MolitchMERussellEJ. The pituitary incidentaloma. Ann Intern Med. 1990;112:925-931.
6.
WallaceISattiNCourtneyC. Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant. J Clin Endocrinol Metab. 2010;95:3268-3271.
7.
OlukogaADornanTKaneJ. Three cases of macroprolactinaemia. J R Soc Med. 1999;92:342-344.
8.
CattaneoFAFahie-WilsonMN. Concomitant occurrence of macroprolactin, exercise-induced amenorrhea, and a pituitary lesion: a diagnostic pitfall: case report. J Neurosurg. 2001;95:334-337.
9.
GlezerABronsteinMD. Approach to the patient with persistent hyperprolactinemia and negative sellar imaging. J Clin Endocrinol Metab. 2012;97:2211-2216.
10.
FideleffHRuibalGBoqueteHPujolASequeraASobradoP. Macroprolactinemia in childhood and adolescence: a cause of asymptomatic hyperprolactinemia. Horm Res. 2000;53:16-19.
11.
HayashidaSAYMarcondesJAMSoaresJM. Evaluation of macroprolactinemia in 259 women under investigation for polycystic ovary syndrome [published online June12, 2013]. Clin Endocrinol (Oxf). doi:10.1111/cen.12266.
